Dr. Jennifer Cunningham, MD (she/her) is an Endocrinologist in Oak park, IL with over 17 years of experience. What is your opinion of Dr. Jennifer Cunningham, MD? Rate this provider below so other people can make informed decision.
Over 17 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Jennifer Cunningham, MD has received over $157,703 which includes payments from the following companies:
$92,319.58 from Novo Nordisk Inc
$54,232.49 from sanofi-aventis U.S. LLC
$3,620.79 from Dexcom, Inc.
$2,052.99 from AstraZeneca Pharmaceuticals LP
$765.91 from Janssen Pharmaceuticals, Inc
$595.63 from LILLY USA, LLC
$445.75 from Boehringer Ingelheim Pharmaceuticals, Inc.
$409.60 from Amgen Inc.
$399.91 from Abbott Laboratories
$291.88 from GlaxoSmithKline, LLC.
$272.63 from Tandem Diabetes Care, Inc.
$247.16 from Otsuka America Pharmaceutical, Inc.
$209.41 from Medtronic MiniMed, Inc.
$193.21 from Merck Sharp & Dohme Corporation
$183.33 from Valeritas, Inc.
$164.03 from Daiichi Sankyo Inc.
$155.71 from AbbVie, Inc.
$140.71 from Takeda Pharmaceuticals America, Inc.
$121.94 from Avinger Inc.
$112.26 from Companion Medical, Inc.
Payments received by Dr. Jennifer Cunningham, MD were from the following categories:
$117,396.50 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!